Notably, we found that SMAD9 expression levels were more than 6-fold higher in NB, similar to the well-known transcripts including PHOX2A, MYCN, TBX2 and GATA3, indicating specificity (Figs. 1A and S2C). This evidence concerns the gene SMAD9 and neuroblastoma.